Detection of Two Transforming Growth Factor-beta-related Morphogens, Bone Morphogenetic Proteins-4 and -5, in RNA of Multiple Sclerosis and Creutzfeldt-Jakob Disease Lesions

Overview

Journal Acta Neuropathol

Specialty Neurology

Date 1995 Jan 1

PMID 7572083

Citations 20

Authors

M Deininger

R Meyermann

H Schluesener

Affiliations

Soon will be listed here.

Abstract

The bone morphogenetic proteins (BMPs) constitute a novel subfamily of the transforming growth factor type beta (TGF-beta) supergene family. Here we demonstrate, using polymerase chain reaction (PCR) BMP-4 and BMP-5 messages in RNA isolated from multiple sclerosis (MS) plaque tissue. This is the first demonstration of BMP expression in an inflammatory lesion in general, and in MS in particular. However, BMP-4 and BMP-5 messages could be detected in RNA isolated from a Morbus Creutzfeldt-Jakob (CJD) lesion. Even in normal brain, RNA expression of BMP-4, but not that of BMP-5, was detected. Therefore, BMP-5 gene expression seems to be associated with MS and CJD lesions, whereas the BMP-4 gene appears to be constitutively expressed in the human brain. As TGF-beta s and BMPs are regulators of regenerative processes and contribute to regulation of chemoattraction and local immunoreactivity, BMP-4 and BMP-5 might be involved in aspects of MS lesion formation unknown so far. PCR analysis of human cell lines demonstrate BMP-4 and BMP-5 expression in leukocytic cells, suggesting that infiltrating leukocytes contribute at least in part to BMP-4 and BMP-5 mRNAs of the MS plaque.

Citing Articles

Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders.

Mausner-Fainberg K, Benhamou M, Golan M, Kimelman N, Danon U, Marom E Neurotherapeutics. 2021; 18(3):1798-1814.

PMID: 34159538 PMC: 8608985. DOI: 10.1007/s13311-021-01068-9.

Overcoming the inhibitory microenvironment surrounding oligodendrocyte progenitor cells following experimental demyelination.

Saraswat D, Shayya H, Polanco J, Tripathi A, Welliver R, Pol S Nat Commun. 2021; 12(1):1923.

PMID: 33772011 PMC: 7998003. DOI: 10.1038/s41467-021-22263-4.

Inhibitors of Myelination and Remyelination, Bone Morphogenetic Proteins, are Upregulated in Human Neurological Disease.

Grinspan J Neurochem Res. 2020; 45(3):656-662.

PMID: 32030597 PMC: 7141772. DOI: 10.1007/s11064-020-02980-w.

Inhibiting Bone Morphogenetic Protein 4 Type I Receptor Signaling Promotes Remyelination by Potentiating Oligodendrocyte Differentiation.

Govier-Cole A, Wood R, Fletcher J, Gonsalvez D, Merlo D, Cate H eNeuro. 2019; 6(2).

PMID: 31028086 PMC: 6529590. DOI: 10.1523/ENEURO.0399-18.2019.

Myelination in Multiple Sclerosis Lesions Is Associated with Regulation of Bone Morphogenetic Protein 4 and Its Antagonist Noggin.

Harnisch K, Teuber-Hanselmann S, Macha N, Mairinger F, Fritsche L, Soub D Int J Mol Sci. 2019; 20(1).

PMID: 30609838 PMC: 6337410. DOI: 10.3390/ijms20010154.

References

Johnson M, Jennings M, Gold L, Moses H . Transforming growth factor-beta in neural embryogenesis and neoplasia. Hum Pathol. 1993; 24(5):457-62. DOI: 10.1016/0046-8177(93)90156-b. View

DAlessandro J, Wang E . Bone morphogenetic proteins induce differentiation in astrocyte lineage cells. Growth Factors. 1994; 11(1):53-69. DOI: 10.3109/08977199409015051. View

Bryant P . Localized cell death caused by mutations in a Drosophila gene coding for a transforming growth factor-beta homolog. Dev Biol. 1988; 128(2):386-95. DOI: 10.1016/0012-1606(88)90300-4. View

Cunningham N, Paralkar V, Reddi A . Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci U S A. 1992; 89(24):11740-4. PMC: 50632. DOI: 10.1073/pnas.89.24.11740. View

Jones C, Lyons K, Hogan B . Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development. 1991; 111(2):531-42. DOI: 10.1242/dev.111.2.531. View

Schluesener H, Meyermann R . TGF-beta 1, beta 2, beta 1.2 and the bone morphogenetic protein BMP2: members of the transforming growth factor type beta supergene family with different morphogenetic effects on rat astrocyte cultures. Autoimmunity. 1991; 9(1):77-81. DOI: 10.3109/08916939108997127. View

Schluesener H, Koeppel C, Jung S . Multidrug transport in human autoimmune T line cells and peripheral blood lymphocytes. Immunopharmacology. 1992; 23(1):37-48. DOI: 10.1016/0162-3109(92)90007-y. View

Perides G, Safran R, Rueger D, Charness M . Induction of the neural cell adhesion molecule and neuronal aggregation by osteogenic protein 1. Proc Natl Acad Sci U S A. 1992; 89(21):10326-30. PMC: 50331. DOI: 10.1073/pnas.89.21.10326. View

Schluesener H, Meyermann R . Spontaneous multidrug transport in human glioma cells is regulated by transforming growth factors type beta. Acta Neuropathol. 1991; 81(6):641-8. DOI: 10.1007/BF00296374. View

10.

Schluesener H, Meyermann R . Intercrines in brain pathology. Expression of intercrines in a multiple sclerosis and Morbus Creutzfeldt-Jakob lesion. Acta Neuropathol. 1993; 86(4):393-6. DOI: 10.1007/BF00369453. View

11.

Wozney J, Rosen V, Celeste A, Mitsock L, Whitters M, Kriz R . Novel regulators of bone formation: molecular clones and activities. Science. 1988; 242(4885):1528-34. DOI: 10.1126/science.3201241. View

12.

Finch C, Laping N, Morgan T, Nichols N, Pasinetti G . TGF-beta 1 is an organizer of responses to neurodegeneration. J Cell Biochem. 1993; 53(4):314-22. DOI: 10.1002/jcb.240530408. View

13.

Flanders K, Ludecke G, Engels S, Cissel D, Roberts A, Kondaiah P . Localization and actions of transforming growth factor-beta s in the embryonic nervous system. Development. 1991; 113(1):183-91. DOI: 10.1242/dev.113.1.183. View

14.

Sheppard A, Hamilton S, PEARLMAN A . Changes in the distribution of extracellular matrix components accompany early morphogenetic events of mammalian cortical development. J Neurosci. 1991; 11(12):3928-42. PMC: 6575290. View

15.

Bentley H, Hamdy F, Hart K, Seid J, Williams J, Johnstone D . Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer. 1992; 66(6):1159-63. PMC: 1978039. DOI: 10.1038/bjc.1992.427. View

16.

Paralkar V, Weeks B, Yu Y, Kleinman H, Reddi A . Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen. J Cell Biol. 1992; 119(6):1721-8. PMC: 2289768. DOI: 10.1083/jcb.119.6.1721. View

17.

Lyons K, Pelton R, Hogan B . Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development. Genes Dev. 1989; 3(11):1657-68. DOI: 10.1101/gad.3.11.1657. View

18.

Wozney J . The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev. 1992; 32(2):160-7. DOI: 10.1002/mrd.1080320212. View

19.

Graham A, Francis-West P, Brickell P, Lumsden A . The signalling molecule BMP4 mediates apoptosis in the rhombencephalic neural crest. Nature. 1994; 372(6507):684-6. DOI: 10.1038/372684a0. View

20.

Rosen V, Thies R . The BMP proteins in bone formation and repair. Trends Genet. 1992; 8(3):97-102. DOI: 10.1016/0168-9525(92)90197-c. View